Alliance Pharma Plc

Alliance Pharma (APH)

Company name:Alliance Pharma Plc
EPIC:APHTrading Currency:GBX
Market Sector:AS50ISIN:GB0031030819
Market Segment:AMSMShare Type:DE
WWW Address:Description:ORD 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 100.40 0.0 [0.00] 99.70 100.40 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 538.57 536.42 0.01 1.54 1.61 65.19 1.60 110.80 - 72.20

Alliance Pharma Key Figures

(at previous day's close)
Market Cap.538.57m
Shares In Issue536.42m
Prev. Close100.40
PE Ratio65.19 
Dividend Yield1.60%
EPS - basic1.54p
Dividend PS1.61p
Dividend Cover0.96 
Cash Flow PS7.75p
Return On Equity (ROE)2.86%
Operating Margin10.03%
PEG Factor-0.93 
EPS Growth Rate-69.74%
Dividends PS Growth Rate198.15%
Net Debt199.00m
Gross Gearing44.79%
Quick Assets56.15m
Net Working Capital48.88m
Intangibles / Fixed Assets96.06%
Turnover PS24.20p
Pre-Tax Profit PS2.43p
Retained Profit PS0.97p
Cash PS5.39p
Net Cash PS-0.24p
Net Tangible Asset Value PS *-24.59p
Net Asset Value PS52.38p
Spread0.70 (0.70%) 

Alliance Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week103.2099.00
4 weeks104.8099.00
12 weeks109.2098.70
1 year110.8072.20

Share Price Chart (5 years)

Alliance Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week103.20-2.80-2.7199.001.02101.51
4 weeks103.40-3.00-2.9099.000.82102.64
12 weeks109.20-8.80-8.0698.700.80103.54
26 weeks100.000.400.4096.501.01102.63
1 year74.1026.3035.4972.201.2693.43
3 years66.8033.6050.3057.101.0381.73
5 years44.2556.15126.8944.001.1076.41

Alliance Pharma Key Management Ratios

Alliance Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio80.40 
PE Ratio65.19 
Tobin's Q Ratio 1.18 
Tobin's Q Ratio (excl. intangibles)6.16 
Dividend Yield1.60%
Market-to-Book Ratio1.92 
Price-to-Pre-Tax Profit PS41.38 
Price-to-Retained Profit PS103.77 
Price-to-Cash Flow PS12.96 
Price-to-Sales PS4.15 
Price-to-Net Tangible Asset Value PS-4.08 
Price-to-Cash PS18.64 
Net Working Capital PS9.11 
Price Pct to Working Capital PS11.02%
Earnings Yield1.53%
Average PE23.02 
Years in average5 
PE to PE average283.22%

Alliance Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio41.30%
Debt-to-Equity Ratio0.70 
Debt-to-Equity Ratio (excl. Intgbl)-1.50 
Debt-to-Equity Market Value0.37 
Net Gearing39.11%
Net Gearing (excl. Intangibles)207.33%
Gross Gearing44.79%
Gross Gearing (excl. Intangibles)237.44%
Gearing Under 1 Year5.93%
Gearing Under 1 Year (excl. Intgbl)31.45%
(Liquidity Ratios)
Net Working Capital to Total Assets9.61%
Current Ratio2.62 
Quick Ratio (Acid Test)1.86 
Liquidity Ratio0.96 
Cash & Equiv/Current Assets36.55%
(Solvency Ratios)
Enterprise Value707.38m
CFO/Attributable Profit5.18 
Total Debt/Equity Market Value0.42 
Total Debt/Sales1.76 
Total Debt/Pre-Tax Profit17.51 
Total Debt227.89m
Total Debt/Net Current Assets4.66%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs8 
Beta (60-Mnth)Beta (36-Mnth)

Alliance Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)2.72%
Return On Assets (ROA)1.75%
Net Profit Margin6.18%
Assets Turnover0.28 
Return On Equity (ROE)2.86%
Return On Investment (ROI)1.86%
Dividend Payout Ratio104.55%
Plowback Ratio-4.55%
Growth from Plowback Ratio-0.13%
Net Income Of Revenues4.00%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.47 
Fixed Assets Turnover0.34 
Current Assets Turnover1.79 
Net Working Capital Turnover 
Inventory Turnover6.75 
(Other Operating Ratios)
Total Assets-to-Sales3.53 
Debt Collection Period84.30Days

Alliance Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
21 Sep 2021InterimGBX0.5631/12/202031/12/202123/12/202124/12/202107/01/2022-
23 Mar 2021FinalGBX1.0831/12/201931/12/202010/06/202111/06/202108/07/20211.61
22 Sep 2020InterimGBX0.5331/12/201931/12/202017/12/202018/12/202007/01/2021-
24 Sep 2019InterimGBX0.5431/12/201831/12/201919/12/201920/12/201910/01/20200.54
26 Mar 2019FinalGBX0.9831/12/201731/12/201813/06/201914/06/201911/07/20191.47
19 Sep 2018InterimGBX0.4931/12/201731/12/201820/12/201821/12/201810/01/2019-
27 Mar 2018FinalGBX0.8931/12/201631/12/201714/06/201815/06/201811/07/20181.33
13 Sep 2017InterimGBX0.4431/12/201631/12/201721/12/201722/12/201711/01/2018-
29 Mar 2017FinalGBX0.8131/12/201531/12/201615/06/201716/06/201712/07/20171.21
14 Sep 2016InterimGBX0.4031/12/201531/12/201622/12/201623/12/201612/01/2017-
07 Apr 2016FinalGBX0.7431/12/201431/12/201516/06/201617/06/201613/07/20161.10
09 Sep 2015InterimGBX0.3631/12/201431/12/201524/12/201529/12/201514/01/2016-
25 Mar 2015FinalGBX0.6731/12/201331/12/201418/06/201519/06/201515/07/20151.00
10 Sep 2014InterimGBX0.3331/12/201331/12/201403/12/201405/12/201415/01/2015-
26 Mar 2014FinalGBX0.6131/12/201231/12/201311/06/201413/06/201410/07/20140.91
11 Sep 2013InterimGBX0.3031/12/201231/12/201304/12/201306/12/201315/01/2014-
21 Mar 2013FinalGBX0.5531/12/201131/12/201212/06/201314/06/201311/07/20130.83
12 Sep 2012InterimGBX0.2831/12/201131/12/201205/12/201207/12/201215/01/2013-
22 Mar 2012FinalGBX0.5031/12/201031/12/201113/06/201215/06/201212/07/20120.75
07 Sep 2011InterimGBX0.2531/12/201031/12/201130/11/201102/12/201113/01/2012-
23 Mar 2011FinalGBX0.4031/12/200931/12/201015/06/201117/06/201114/07/20110.57
08 Sep 2010InterimGBX0.1731/12/200931/12/201001/12/201003/12/201014/01/2011-
24 Mar 2010FinalGBX0.2331/12/200831/12/200916/06/201018/06/201015/07/20100.30
09 Sep 2009InterimGBX0.0730/12/200830/06/200902/12/200904/12/200915/01/2010-

Alliance Pharma Fundamentals

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
pre tax profit28.3727.46%22.8019.29%32.8924.25%13.0210.03%m
attributable profit28.9127.98%18.3615.53%26.4819.52%8.036.18%m
retained profit23.1822.44%12.0110.16%18.8813.92%5.194.00%m
eps - basic (p)6.10 3.69 5.09 1.54 
eps - diluted (p)6.03 3.60 4.99 1.52 
dividends per share1.33 1.47 0.54 1.61 

Alliance Pharma Balance Sheet

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
fixed assets fixed assets3.381.00%7.591.88%11.552.83%15.923.13%m
intangibles intangibles278.6282.81%335.2483.06%328.6680.63%412.8781.14%m
fixed investments fixed investments1.710.51%0.180.04%1.370.34%0.990.19%m
current assets - other current assets - other--%--%--%--%m
stocks stocks14.254.23%18.714.63%15.523.81%22.924.50%m
debtors debtors27.338.12%30.997.68%32.708.02%27.255.36%m
cash & securities cash & securities11.183.32%10.892.70%17.834.37%28.905.68%m
creditors - short creditors - short60.8118.07%91.7222.73%24.215.94%30.195.93%m
creditors - long creditors - long72.2921.48%59.6914.79%109.2526.80%197.7138.85%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves203.3860.44%252.2062.49%274.1867.26%280.9655.21%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Alliance Pharma Cash Flow Statement

31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
Operating CF26.5822.1735.7641.57m
Pre-Financing CF10.67-36.9132.47-44.30m
Retained CF4.22-0.337.2811.45m

Alliance Pharma Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20211203 07:32:07